Liposomes as immunological adjuvants for tetanus vaccine
Popescu, C.; Durbaca, S.; Ivanov, D.
Roumanian Archives of Microbiology and Immunology 57(3-4): 263-269
1998
ISSN/ISBN: 1222-3891 PMID: 11845438 Document Number: 497306
Finding a new immunological adjuvant has been a challenge all along. The aim of our study is to improve the level of antibodies against tetanus using liposomes as adjuvant. As can be seen from the results of our study, the liposomes are a competitive candidate in this respect.
Document emailed within 1 workday
Related Documents
Kerdpanich, A.; Hutagalung, Y.; Watanaveeradej, V.; Bock, H.L.; Steinhoffmd, M. 2007: The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine Journal of the Medical Association of Thailand 90(7): 1330-1336Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Gil', I.V.; Sokhin, A.A.; Sliusar', L.I.; Vereshchagina, V.I.; Radomskaia, F.S. 1989: Epidemiological and immunological features of tetanus under conditions of long-term planned vaccine prophylaxis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 38-43
Beuvery, E.C.; Speijers, G.J.; Lutz, B.I.; Freudenthal, D.; Kanhai, V.; Haagmans, B.; Derks, H.J. 1986: Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use Developments in Biological Standardization 63: 117-128
Paraf, A. 1970: Mechanism of action of immunological adjuvants Annales de l'Institut Pasteur 118(4): 419-441
Domorázková, E.; Drevo, M.; Burian, V.; Burianová-Vysoká, B.; Janotová, J.; Kratochvílová, M.; Kríz, J.; Vodicková, M.; Kyselová, M. 1973: Use of live measles vaccine in the 3d injection of basic DTPA vaccine (Diphtheria, Tetanus, Pertussia Antitoxin) Ceskoslovenska Pediatrie 28(3): 129-130
Bitragunta, S.; Murhekar, M.V.; Chakravarti, A.; Verma, V.; Namjoshi, G.S.; Parekh, S.S.; Sharma, H.J.; Kumar, B.K.; Gupte, M.D. 2010: Safety and immunogenicity of single dose of tetanus-diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007 Vaccine 28(37): 5934-5938
Tanaka, A.; Ishibashi, T.; Sugiyama, K.; Takamoto, M. 1971: Immunological adjuvants. VI. An acetylated mycobacterial adjuvant lacking competing antigenicity Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 142(4): 303-317
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Sanchez-Pescador, L.; Burke, R.L.; Ott, G.; Van Nest, G. 1988: The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine Journal of Immunology 141(5): 1720-1727
Anonymous 2002: 1st International and 2nd National Workshop on Vaccine Adjuvants, Havana, Cuba, December 5-8, 2001 Biotecnologia Aplicada 19(1-2): 49-96
Goodman, M.G. 1995: A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine Pharmaceutical Biotechnology 6: 581-609
Ishibashi, T.; Tanaka, A.; Koashi, O.; Sugiyama, K. 1975: The mode of action of immunological adjuvants. II. Generation of a potent precursor of antibody-forming cell by adjuvant Japanese Journal of Experimental Medicine 45(3): 147-154
Valensi, J.P.; Carlson, J.R.; Van Nest, G.A. 1994: Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants Journal of Immunology 153(9): 4029-4039
Prager, J.; Baumert, A.; Thilo, W.; Hermann, J.; Fuchs, D.; Sauerbrey, A.; Zintl, F. 1992: The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: the kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus Kinderarztliche Praxis 60(8): 230-238
Efremenko, V.I. 2015: Effect of Intact Bionanostructures--Liposomes on Biochemical and Immunological Status of the Organism Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 80-88
Tiwari, S.; Goyal, A.K.; Khatri, K.; Mishra, N.; Vyas, S.P. 2009: Gel core liposomes: an advanced carrier for improved vaccine delivery Journal of Microencapsulation 26(1): 75-82
Cao, S-Chun.; Li, J-Dong.; Lu, P.; Liu, F.; Wang, Q.; Liu, Q-Zhi.; Zhang, Q-Fu.; Li, C.; An, Q.; Liang, M-Fang.; Li, D-Xin. 2008: Hantavirus mucosal vaccine through different mucosal with heat-labile enterotoxin B subunit as adjuvants Zhonghua Shi Yan He Lin Chuang Bing du Xue Za Zhi 22(3): 174-176
Kurashvili, V.A.; Dgebuadze, I.Sh. 2003: Epidemiological and immunological monitoring of tetanus in Georgia (Republic) Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2003(1): 70-72
Gefen, N.E.; Egorova, N.B.; Miroshnichenko, I.V.; Vorontsov, I.V.; Severtsova, M.K. 1974: Results of observing the immunological status to tetanus in young people Voenno-Meditsinskii Zhurnal 1: 54-56